{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:58:01Z","timestamp":1781614681507,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060529"],"award-info":[{"award-number":["82060529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>RAB3A, a member of the RAS oncogene family, plays a central role in regulated exocytosis and secretion. However, its function, molecular mechanism, and clinical significance in non-small cell lung cancer(NSCLC) remain largely undetermined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the expression of RAB3A and its correlation with overall survival using multiple databases and immunohistochemistry staining. The oncogenic role of RAB3A in NSCLC was investigated through various cellular assays, including cell viability and colony formation assays. Protein mass spectrometry experiment, immunoprecipitation, immunofluorescence, subcellular fractionation, mitochondria isolation, cycloheximide assays, and lung cancer xenograft mouse models were performed to clarify the molecular mechanism of RAB3A in NSCLC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The expression of RAB3A was upregulated in NSCLC patients and high level of RAB3A correlated with a poor overall survival. RAB3A depletion inhibited the cell proliferation. Mechanistically, RAB3A knockdown enhanced the nuclear translocation of BAG6-EP300, leading to the acetylation of p53 and Rb. This acetylation strengthened the p53\/Rb signaling pathway, thereby suppressing NSCLC progression. Additionally, RAB3A facilitated the transportation of BAG6 to the mitochondria, promoting mitophagy and increasing resistance to cisplatin in NSCLC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings elucidate the role and underlying mechanisms of RAB3A in NSCLC progression. Thus, RAB3A emerges as a potential prognosis prediction biomarker and therapeutic target for NSCLC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s13402-025-01123-z","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:52:44Z","timestamp":1761123164000},"page":"2001-2015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAB3A-mediated BAG6 translocation promotes non-small cell lung cancer tumorigenesis and progression"],"prefix":"10.1007","volume":"48","author":[{"given":"Xiaoli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"1123_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"key":"1123_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"P. Goldstraw et al., The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 39\u201351 (2016)","journal-title":"J. Thorac. Oncol."},{"key":"1123_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.6004\/jnccn.2022.7021","volume":"20","author":"B Muthusamy","year":"2022","unstructured":"B. Muthusamy, P. Patil, N. Pennell, Perioperative systemic therapy for resectable Non-Small cell lung cancer. J. Natl. Compr. Canc Netw. 20, 953\u2013961 (2022)","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"1123_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1200\/JCO.21.01707","volume":"40","author":"K Higgins","year":"2022","unstructured":"K. Higgins, S. Puri, J. Gray, Systemic and radiation therapy approaches for locally advanced Non-Small-Cell lung cancer. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. 40, 576\u2013585 (2022)","journal-title":"J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol."},{"key":"1123_CR5","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/S0140-6736(19)32795-3","volume":"394","author":"T Lancet","year":"2019","unstructured":"T. Lancet, Lung cancer: some progress, but still a lot more to do. Lancet. 394, 1880 (2019)","journal-title":"Lancet"},{"key":"1123_CR6","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/d41586-020-03152-0","volume":"587","author":"H Brody","year":"2020","unstructured":"H. Brody, Lung cancer. Nature. 587, S7 (2020)","journal-title":"Nature"},{"key":"1123_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","volume":"61","author":"P Harrison","year":"2020","unstructured":"P. Harrison, S. Vyse, P. Huang, Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol. 61, 167\u2013179 (2020)","journal-title":"Semin Cancer Biol."},{"key":"1123_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jtho.2022.10.015","volume":"18","author":"J Remon","year":"2023","unstructured":"J. Remon et al., MET alterations in NSCLC-Current perspectives and future challenges. J. Thorac. Oncol. 18, 419\u2013435 (2023)","journal-title":"J. Thorac. Oncol."},{"key":"1123_CR9","doi-asserted-by":"publisher","first-page":"e48351","DOI":"10.15252\/embr.201948351","volume":"22","author":"Q Tang","year":"2021","unstructured":"Q. Tang et al., Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer. EMBO Rep. 22, e48351 (2021)","journal-title":"EMBO Rep."},{"key":"1123_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7150\/thno.65522","volume":"12","author":"P Yang","year":"2022","unstructured":"P. Yang et al., Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics. 12, 340\u2013361 (2022)","journal-title":"Theranostics"},{"key":"1123_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1083\/jcb.201704184","volume":"217","author":"D Xu","year":"2018","unstructured":"D. Xu et al., Rab18 promotes lipid droplet (LD) growth by tethering the ER to LDs through SNARE and NRZ interactions. J. Cell Biol. 217, 975\u2013995 (2018)","journal-title":"J. Cell Biol."},{"key":"1123_CR12","doi-asserted-by":"crossref","unstructured":"D. Shin et al., Site-specific monoubiquitination downregulates Rab5 by disrupting effector binding and guanine nucleotide conversion. eLife 6, (2017)","DOI":"10.7554\/eLife.29154"},{"key":"1123_CR13","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.7150\/thno.60040","volume":"11","author":"IY Kuo","year":"2021","unstructured":"I.Y. Kuo et al., Converged Rab37\/IL-6 trafficking and STAT3\/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment. Theranostics. 11, 7029\u20137044 (2021)","journal-title":"Theranostics"},{"key":"1123_CR14","doi-asserted-by":"publisher","first-page":"8821","DOI":"10.1111\/jcmm.16841","volume":"25","author":"Y Zhang","year":"2021","unstructured":"Y. Zhang et al., TBC1 domain family member 23 interacts with Ras-related protein Rab-11A to promote poor prognosis of non-small-cell lung cancer via \u03b21-integrin. J. Cell. Mol. Med. 25, 8821\u20138835 (2021)","journal-title":"J. Cell. Mol. Med."},{"key":"1123_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-021-01307-9","volume":"20","author":"S Wu","year":"2021","unstructured":"S. Wu et al., Intercellular transfer of Exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer. Mol. Cancer. 20, 17 (2021)","journal-title":"Mol. Cancer"},{"key":"1123_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.201606006","volume":"213","author":"C Raiborg","year":"2016","unstructured":"C. Raiborg, H. Stenmark, Plasma membrane repairs by small GTPase Rab3a. J. Cell. Biol. 213, 613\u2013615 (2016)","journal-title":"J. Cell. Biol."},{"key":"1123_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1365-2443.1996.00257.x","volume":"1","author":"Y Takai","year":"1996","unstructured":"Y. Takai, T. Sasaki, H. Shirataki, H. Nakanishi, Rab3A small GTP-binding protein in Ca(2+)-dependent exocytosis. Genes Cells. 1, 615\u2013632 (1996)","journal-title":"Genes Cells"},{"key":"1123_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/21541248.2021.1939631","volume":"13","author":"M Izumida","year":"2022","unstructured":"M. Izumida, K. Kakoki, H. Hayashi, T. Matsuyama, Y. Kubo, Rab3a, a small GTP-binding protein, is required for the stabilization of the murine leukaemia virus gag protein. Small GTPases. 13, 162\u2013182 (2022)","journal-title":"Small GTPases"},{"key":"1123_CR19","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1002\/1097-0142(19921115)70:10<2552::AID-CNCR2820701026>3.0.CO;2-Q","volume":"70","author":"S Culine","year":"1992","unstructured":"S. Culine, M.F. Rousseau, N. Honor\u00e9, C. Nezelof, B. Olofsson, Specific expression of the ras-related rab3A gene in human normal and malignant neuroendocrine cells. Cancer. 70, 2552\u20132556 (1992)","journal-title":"Cancer"},{"key":"1123_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/00006676-199407000-00004","volume":"9","author":"B Lankat-Buttgereit","year":"1994","unstructured":"B. Lankat-Buttgereit, H.C. Fehmann, B.J. Hering, R.G. Bretzel, B. G\u00f6ke, Expression of the ras-related rab3a gene in human insulinomas and normal human pancreatic Islets. Pancreas. 9, 434\u2013438 (1994)","journal-title":"Pancreas"},{"key":"1123_CR21","doi-asserted-by":"publisher","first-page":"9092","DOI":"10.1128\/MCB.20.23.9092-9101.2000","volume":"20","author":"RK Vadlamudi","year":"2000","unstructured":"R.K. Vadlamudi et al., Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to Heregulin in mammary epithelial cells. Mol. Cell. Biol. 20, 9092\u20139101 (2000)","journal-title":"Mol. Cell. Biol."},{"key":"1123_CR22","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1007\/s11033-014-3465-2","volume":"41","author":"JK Kim","year":"2014","unstructured":"J.K. Kim et al., Rab3a promotes brain tumor initiation and progression. Mol. Biol. Rep. 41, 5903\u20135911 (2014)","journal-title":"Mol. Biol. Rep."},{"key":"1123_CR23","doi-asserted-by":"publisher","first-page":"e10312","DOI":"10.1371\/journal.pone.0010312","volume":"5","author":"J Hou","year":"2010","unstructured":"J. Hou et al., Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 5, e10312 (2010)","journal-title":"PLoS One"},{"key":"1123_CR24","unstructured":"M. Meister et al., Intra-tumor heterogeneity of gene expression profiles in early stage Non-Small cell lung cancer. J. Bioinf. Res. Stud. 1, (2014)"},{"key":"1123_CR25","doi-asserted-by":"crossref","unstructured":"W. Shen et al., Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta 1, e36 (2022)","DOI":"10.1002\/imt2.36"},{"key":"1123_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fcell.2020.00629","volume":"8","author":"T Zhou","year":"2020","unstructured":"T. Zhou et al., Novel Ten-Gene signature predicting prognosis in hepatocellular carcinoma. Front. cell. Dev. Biology. 8, 629 (2020)","journal-title":"Front. cell. Dev. Biology"},{"key":"1123_CR27","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","volume":"8","author":"B Gy\u0151rffy","year":"2013","unstructured":"B. Gy\u0151rffy, P. Surowiak, J. Budczies, A. L\u00e1nczky, Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PloS One. 8, e82241 (2013)","journal-title":"PloS One"},{"key":"1123_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41467-020-14870-4","volume":"11","author":"X Wang","year":"2020","unstructured":"X. Wang et al., Targeting the CK1\u03b1\/CBX4 axis for metastasis in osteosarcoma. Nat. Commun. 11, 1141 (2020)","journal-title":"Nat. Commun."},{"key":"1123_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/bies.201200159","volume":"35","author":"JG Lee","year":"2013","unstructured":"J.G. Lee, Y. Ye, Bag6\/Bat3\/Scythe: a novel chaperone activity with diverse regulatory functions in protein biogenesis and degradation. BioEssays. 35, 377\u2013385 (2013)","journal-title":"BioEssays"},{"key":"1123_CR30","doi-asserted-by":"publisher","first-page":"e21361","DOI":"10.1096\/fj.202000930R","volume":"35","author":"R Ragimbeau","year":"2021","unstructured":"R. Ragimbeau et al., BAG6 promotes PINK1 signaling pathway and is essential for mitophagy. Faseb j. 35, e21361 (2021)","journal-title":"Faseb j."},{"key":"1123_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jb\/mvs149","volume":"153","author":"H Kawahara","year":"2013","unstructured":"H. Kawahara, R. Minami, N. Yokota, BAG6\/BAT3: emerging roles in quality control for nascent polypeptides. J. BioChem. 153, 147\u2013160 (2013)","journal-title":"J. BioChem."},{"key":"1123_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4161\/auto.28979","volume":"10","author":"S Sebti","year":"2014","unstructured":"S. Sebti et al., BAG6\/BAT3 modulates autophagy by affecting EP300\/p300 intracellular localization. Autophagy. 10, 1341\u20131342 (2014)","journal-title":"Autophagy"},{"key":"1123_CR33","doi-asserted-by":"crossref","unstructured":"M. Schuldner et al., Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP\/p300-dependent acetylation of p53. Theranostics 9, 6047\u20136062 (2019)","DOI":"10.7150\/thno.36378"},{"key":"1123_CR34","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.1313618111","volume":"111","author":"S Sebti","year":"2014","unstructured":"S. Sebti et al., BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy. Proc. Natl. Acad. Sci. U.S.A. 111, 4115\u20134120 (2014)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1123_CR35","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.1158\/0008-5472.CAN-05-0054","volume":"65","author":"Q Deng","year":"2005","unstructured":"Q. Deng et al., The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300\/CBP and Rb family proteins. Cancer Res. 65, 8298\u20138307 (2005)","journal-title":"Cancer Res."},{"key":"1123_CR36","doi-asserted-by":"publisher","first-page":"14932","DOI":"10.1021\/jacs.3c04640","volume":"145","author":"M Kabir","year":"2023","unstructured":"M. Kabir et al., Acetylation targeting chimera enables acetylation of the tumor suppressor p53. J. Am. Chem. Soc. 145, 14932\u201314944 (2023)","journal-title":"J. Am. Chem. Soc."},{"key":"1123_CR37","doi-asserted-by":"publisher","first-page":"51163","DOI":"10.1074\/jbc.M409024200","volume":"279","author":"K Balasubramanyam","year":"2004","unstructured":"K. Balasubramanyam et al., Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J. Biol. Chem. 279, 51163\u201351171 (2004)","journal-title":"J. Biol. Chem."},{"key":"1123_CR38","doi-asserted-by":"publisher","first-page":"118856","DOI":"10.1016\/j.bbamcr.2020.118856","volume":"1868","author":"Y Li","year":"2021","unstructured":"Y. Li et al., NIR promotes progression of colorectal cancer through regulating RB. Biochim. Et Biophys. Acta Mol. cell. Res. 1868, 118856 (2021)","journal-title":"Biochim. Et Biophys. Acta Mol. cell. Res."},{"key":"1123_CR39","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S1097-2765(01)00414-2","volume":"8","author":"NA Barlev","year":"2001","unstructured":"N.A. Barlev et al., Acetylation of p53 activates transcription through recruitment of coactivators\/histone acetyltransferases. Mol. Cell. 8, 1243\u20131254 (2001)","journal-title":"Mol. Cell."},{"key":"1123_CR40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"M. Wang, R. Herbst, C. Boshoff, Toward personalized treatment approaches for non-small-cell lung cancer. Nat. Med. 27, 1345\u20131356 (2021)","journal-title":"Nat. Med."},{"key":"1123_CR41","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.tcb.2018.06.007","volume":"28","author":"L Langemeyer","year":"2018","unstructured":"L. Langemeyer, F. Fr\u00f6hlich, C. Ungermann, Rab GTPase function in endosome and lysosome biogenesis. Trends Cell. Biol. 28, 957\u2013970 (2018)","journal-title":"Trends Cell. Biol."},{"key":"1123_CR42","doi-asserted-by":"publisher","first-page":"C97","DOI":"10.1152\/ajpcell.00366.2008","volume":"296","author":"F Domoki","year":"2009","unstructured":"F. Domoki et al., Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. Am. J. Physiol. Cell. Physiol. 296, C97\u2013105 (2009)","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"1123_CR43","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1074\/mcp.M700478-MCP200","volume":"7","author":"H Lu","year":"2008","unstructured":"H. Lu, Y. Yang, E.M. Allister, N. Wijesekara, M.B. Wheeler, The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol. Cell. Proteomics: MCP. 7, 1434\u20131451 (2008)","journal-title":"Mol. Cell. Proteomics: MCP"},{"key":"1123_CR44","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1210\/en.2011-0259","volume":"153","author":"JH Park","year":"2012","unstructured":"J.H. Park et al., Glucagon-like peptide-1 enhances glucokinase activity in pancreatic \u03b2-cells through the association of Epac2 with Rim2 and Rab3A. Endocrinology. 153, 574\u2013582 (2012)","journal-title":"Endocrinology"},{"key":"1123_CR45","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41419-018-0961-7","volume":"9","author":"W Wu","year":"2018","unstructured":"W. Wu et al., O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma. Cell. Death Dis. 9, 970 (2018)","journal-title":"Cell. Death Dis."},{"key":"1123_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/2211-5463.12677","volume":"9","author":"M Hayashishita","year":"2019","unstructured":"M. Hayashishita, H. Kawahara, N. Yokota, BAG6 deficiency induces mis-distribution of mitochondrial clusters under depolarization. FEBS open. Bio. 9, 1281\u20131291 (2019)","journal-title":"FEBS open. Bio"},{"key":"1123_CR47","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1074\/jbc.RA119.010474","volume":"295","author":"M Verma","year":"2020","unstructured":"M. Verma, J. Zhu, K.Z.Q. Wang, C.T. Chu, Chronic treatment with the complex I inhibitor MPP(+) depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6). J. Biol. Chem. 295, 7865\u20137876 (2020)","journal-title":"J. Biol. Chem."},{"key":"1123_CR48","doi-asserted-by":"publisher","first-page":"14562","DOI":"10.1074\/jbc.RA119.008544","volume":"294","author":"K Kamikubo","year":"2019","unstructured":"K. Kamikubo et al., A molecular triage process mediated by RING finger protein 126 and BCL2-associated athanogene 6 regulates degradation of G(0)\/G(1) switch gene 2. J. Biol. Chem. 294, 14562\u201314573 (2019)","journal-title":"J. Biol. Chem."},{"key":"1123_CR49","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/febs.13618","volume":"283","author":"H Tanaka","year":"2016","unstructured":"H. Tanaka et al., A conserved Island of BAG6\/Scythe is related to ubiquitin domains and participates in short hydrophobicity recognition. FEBS J. 283, 662\u2013677 (2016)","journal-title":"FEBS J."},{"key":"1123_CR50","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1007\/s11033-014-3263-x","volume":"41","author":"SS Lodhi","year":"2014","unstructured":"S.S. Lodhi, R. Farmer, A.K. Singh, Y.K. Jaiswal, G. Wadhwa, 3D structure generation, virtual screening and Docking of human Ras-associated binding (Rab3A) protein involved in tumourigenesis. Mol. Biol. Rep. 41, 3951\u20133959 (2014)","journal-title":"Mol. Biol. Rep."},{"key":"1123_CR51","doi-asserted-by":"crossref","unstructured":"T. Takahashi et al., Cytoplasmic control of Rab family small GTPases through BAG6. EMBO Rep. 20, (2019)","DOI":"10.15252\/embr.201846794"},{"key":"1123_CR52","doi-asserted-by":"publisher","first-page":"9715","DOI":"10.1074\/jbc.M211352200","volume":"278","author":"K Yaekura","year":"2003","unstructured":"K. Yaekura et al., Insulin secretory deficiency and glucose intolerance in Rab3A null mice. J. Biol. Chem. 278, 9715\u20139721 (2003)","journal-title":"J. Biol. Chem."},{"key":"1123_CR53","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.1523\/JNEUROSCI.0168-16.2016","volume":"36","author":"Y Hong","year":"2016","unstructured":"Y. Hong, T. Zhao, X.J. Li, S. Li, Mutant Huntingtin impairs BDNF release from astrocytes by disrupting conversion of Rab3a-GTP into Rab3a-GDP. J. Neurosci. 36, 8790\u20138801 (2016)","journal-title":"J. Neurosci."},{"key":"1123_CR54","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jcb.29948","volume":"122","author":"R Raffaniello","year":"2021","unstructured":"R. Raffaniello, Rab3 proteins and cancer: exit strategies. J. Cell. Biochem. 122, 1295\u20131301 (2021)","journal-title":"J. Cell. Biochem."},{"key":"1123_CR55","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","volume":"65","author":"X Qian","year":"2017","unstructured":"X. Qian et al., Phosphoglycerate kinase 1 phosphorylates Beclin1 to induce autophagy. Mol. Cell. 65, 917\u2013931e916 (2017)","journal-title":"Mol. Cell"},{"key":"1123_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3164\/jcbn.23-1","volume":"73","author":"Z Zhang","year":"2023","unstructured":"Z. Zhang et al., Mitophagy-mediated inflammation and oxidative stress contribute to muscle wasting in cancer cachexia. J. Clin. Biochem. Nutr. 73, 34\u201342 (2023)","journal-title":"J. Clin. Biochem. Nutr."},{"key":"1123_CR57","doi-asserted-by":"crossref","unstructured":"D. Shi, W. Liu, X. Zhang, Y. Zhang, B. Luo, MiR-BART1-3p and BART18-5p inhibit cell migration, proliferation and activate autophagy in Epstein-Barr virus-associated gastric cancer by targeting erythropoietin-producing human hepatocellular 2. Virus genes, (2023)","DOI":"10.1007\/s11262-023-02023-w"},{"key":"1123_CR58","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/15548627.2017.1313945","volume":"13","author":"X Qian","year":"2017","unstructured":"X. Qian, X. Li, Z. Lu, Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis. Autophagy. 13, 1246\u20131247 (2017)","journal-title":"Autophagy"},{"key":"1123_CR59","first-page":"1866","volume":"43","author":"CL Wu","year":"2019","unstructured":"C.L. Wu et al., Beclin1 Inhibition enhances paclitaxel\u2013mediated cytotoxicity in breast cancer in vitro and in vivo. Int. J. Mol. Med. 43, 1866\u20131878 (2019)","journal-title":"Int. J. Mol. Med."},{"key":"1123_CR60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/26506","volume":"395","author":"N Mizushima","year":"1998","unstructured":"N. Mizushima et al., A protein conjugation system essential for autophagy. Nature. 395, 395\u2013398 (1998)","journal-title":"Nature"},{"key":"1123_CR61","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","volume":"86","author":"NA dos Santos","year":"2012","unstructured":"N.A. dos Santos, M.A. Carvalho Rodrigues, N.M. Martins, Dos Santos, Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch. Toxicol. 86, 1233\u20131250 (2012)","journal-title":"Arch. Toxicol."},{"key":"1123_CR62","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1080\/15548627.2019.1591672","volume":"15","author":"BL Baechler","year":"2019","unstructured":"B.L. Baechler, D. Bloemberg, J. Quadrilatero, Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation. Autophagy. 15, 1606\u20131619 (2019)","journal-title":"Autophagy"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01123-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:19:38Z","timestamp":1781612378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01123-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01123-z","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the principles of the Declaration of Helsinki. Informed consent was obtained from all the subjects. Ethics approval for human subjects was provided by the Medical Research Ethics Committee of the Fifth Affiliated Hospital of Sun Yat-sen University (2023-K172-1). Ethics approval for animal work was provided by the Animal Ethics Committee of First Affiliated Hospital of Xinjiang Medical University (IACUC-20200331-102).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}